Status of multidrug resistant tuberculosis (MDR-TB) among the Sahariya tribe of North Central India

Status of multidrug resistant tuberculosis (MDR-TB) among the Sahariya tribe of North Central India

Summary: Background: The incidence/prevalence of tuberculosis (TB) is reported to be high in the Sahariya tribe of North Central India. The outbreaks of different drug-resistant isolates of Mycobacterium tuberculosis emphasized the need for continuous monitoring of resistance to anti-tuberculosis d...

Full description

Bibliographic Details
Main Authors:	Ravi Prakash, Dilip Kumar, Vinod K. Gupta, Sanjay Jain, Devendra S. Chauhan, Pramod K. Tiwari, Vishwa M. Katoch
Format:	Article
Language:	English
Published:	Elsevier 2016-05-01
Series:	Journal of Infection and Public Health
Online Access:	http://www.sciencedirect.com/science/article/pii/S1876034115001914

Similar Items

Spoligotyping, phenotypic and genotypic characterization of katG, rpoB gene of M. tuberculosis isolates from Sahariya tribe of Madhya Pradesh India
by: Rahul Gupta, et al.
Published: (2019-05-01)

Molecular modelling and docking analysis of katG and rpoB gene in MDR-TB isolates from North Central Indian population
by: Ravi Prakash, et al.
Published: (2017-09-01)

Increased prevalence of pulmonary tuberculosis in male adults of sahariya tribe of India: A revised survey
by: Sharma P, et al.
Published: (2010-01-01)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
by: Monadil H. Ali, et al.
Published: (2019-07-01)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
by: Natasha F. Sabur, et al.
Published: (2021-03-01)

Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
by: Holly A. Taylor, et al.
Published: (2022-12-01)

Management of multidrug resistant tuberculosis (MDR-TB) – Monitoring is the key to successful
by: J.S. Akshata, et al.
Published: (2016-04-01)

‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility
by: Ying Zhang, et al.
Published: (2012-07-01)

Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali
by: Bocar Baya, et al.
Published: (2019-04-01)

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
by: Noura M. Al-Mutairi, et al.
Published: (2019-12-01)

Identification of Serum Cytokine Biomarkers Associated with Multidrug Resistant Tuberculosis (MDR-TB)
by: Gloria Ivy Mensah, et al.
Published: (2021-10-01)

Dimensions of nutritional vulnerability: Assessment of women and children in Sahariya tribal community of Madhya Pradesh in India
by: Suparna Ghosh-Jerath, et al.
Published: (2013-01-01)

Correction to: Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
by: Noura M. Al-Mutairi, et al.
Published: (2020-04-01)

Clinical profile and risk stratification in multidrug-resistant tuberculosis (MDR-TB) and non-MDR-TB patients: A prospective study in a tertiary care hospital
by: Kumar NS, et al.
Published: (2021-08-01)

HUBUNGAN DUKUNGAN KELUARGA DENGAN EFIKASI DIRI PENDERITA TUBERCULOSIS MULTIDRUG RESISTANT (TB-MDR) DI POLI TB-MDR RSUD IBNU SINA GRESIK
by: Mar'atul Hasanah, et al.
Published: (2018-12-01)

Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016
by: Shelby PW, et al.
Published: (2017-06-01)

Bedaquiline (BDQ) resistance in an adolescent with multidrug-resistant tuberculosis (MDR-TB): An alarm for pediatricians
by: Citra Cesilia, et al.
Published: (2023-01-01)

Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
by: Betty R. Mchaki, et al.
Published: (2023-02-01)

Patterns of treatment interruption among patients with multidrug-resistant TB (MDR TB) and association with interim and final treatment outcomes.
by: Laura Jean Podewils, et al.
Published: (2013-01-01)

Study of the prevalence of Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB) in Western Rajasthan using line probe assay
by: Mukesh Sharma, et al.
Published: (2020-01-01)

MDR-TB TREATMENT UPDATE
by: Sean Wasserman
Published: (2023-05-01)

MDR TB Transmission, Singapore
by: Cynthia B.E. Chee, et al.
Published: (2013-07-01)

DROP OUT PENGOBATAN PADA TUBERKULOSIS MULTIDRUG RESISTANT (TB MDR) DI KOTA SEMARANG
by: Akhsanu Amala, et al.
Published: (2021-06-01)

Psychiatric disorders in patients with multidrug resistant tuberculosis (MDR-TB) in Sardjito Hospital, Yogyakarta, Indonesia
by: Irwan Supriyanto, et al.
Published: (2017-08-01)

Epidemiology and spatial distribution of cases of multidrug-resistant tuberculosis (mdr-tb) in Brazil, 2008-2012
by: Manoel Guedes de Almeida, et al.
Published: (2013-10-01)

Linkage of presumptive multidrug resistant tuberculosis (MDR-TB) patients to diagnostic and treatment services in Cambodia.
by: Sokhan Khann, et al.
Published: (2013-01-01)

Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: A prospective study
by: Sangita V. Patel, et al.
Published: (2016-07-01)

First outbreak of multidrug-resistant tuberculosis (MDR-TB) in Denmark involving six Danish-born cases
by: Camilla Hiul Suppli, et al.
Published: (2022-04-01)

Factors associated with multidrug-resistant tuberculosis (MDR-TB) in Bhutan: A nationwide case-control study.
by: Chador Tenzin, et al.
Published: (2020-01-01)

MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis.
by: Emily A Kendall, et al.
Published: (2017-01-01)

RELATIONSHIP BETWEEN DETECTION OF TB AND TREATMENT OF MDR/XDR TB
by: V. Guseva, et al.
Published: (2023-08-01)

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar.
by: Pyae Phyo Wai, et al.
Published: (2018-01-01)

Carpe diem (‘Seize the day’): Building on the findings of the 2015 World Health Organization evaluation of the multidrug-resistant tuberculosis (MDR-TB) programme to make the most of shortened MDR-TB treatment in South Africa
by: M Loveday, et al.
Published: (2017-03-01)

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
by: Pravin K. Singh, et al.
Published: (2019-09-01)

Anxiety and depression level of patients with multidrug-resistant tuberculosis (MDR-TB) in two hospitals in Banten province, Indonesia
by: Tirta Darmawan Susanto, et al.
Published: (2023-12-01)

KARAKTERISTIK PENDERITA TUBERKULOSIS PARU DENGAN MULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB) DI RSUD ULIN BANJARMASIN
by: Gusti Andhika Azwar, et al.
Published: (2017-05-01)

Alcohol use disorders in multidrug resistant tuberculosis (MDR-TB) patients and their non-tuberculosis family contacts in Nigeria
by: Victor Olufolahan Lasebikan, et al.
Published: (2020-08-01)

MULTIDRUG RESISTANCE (MDR) OF V. Parahaemolyticus
by: Marlina -
Published: (2015-02-01)

TB MDR Primer dengan Limfadenitis TB pada Wanita SLE [Primary Multidrug-Resistant Tuberculosis Mixed with Lymphadenitis Tuberculosis in a Woman with SLE]
by: Ika Yunita Sari, et al.
Published: (2015-09-01)

The Correlations of Minimal Inhibitory Concentration Values of Anti-TB Drugs with Treatment Outcomes and Clinical Profiles in Patients with Multidrug-Resistant Tuberculosis (MDR-TB) in China
by: Tang Q, et al.
Published: (2022-09-01)